These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 28559345)

  • 1. Peripheral modifications of [Ψ[CH
    Okano A; Isley NA; Boger DL
    Proc Natl Acad Sci U S A; 2017 Jun; 114(26):E5052-E5061. PubMed ID: 28559345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maxamycins: Durable Antibiotics Derived by Rational Redesign of Vancomycin.
    Wu ZC; Boger DL
    Acc Chem Res; 2020 Nov; 53(11):2587-2599. PubMed ID: 33138354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total syntheses and initial evaluation of [Ψ[C(═S)NH]Tpg⁴]vancomycin, [Ψ[C(═NH)NH]Tpg⁴]vancomycin, [Ψ[CH₂NH]Tpg⁴]vancomycin, and their (4-chlorobiphenyl)methyl derivatives: synergistic binding pocket and peripheral modifications for the glycopeptide antibiotics.
    Okano A; Nakayama A; Wu K; Lindsey EA; Schammel AW; Feng Y; Collins KC; Boger DL
    J Am Chem Soc; 2015 Mar; 137(10):3693-704. PubMed ID: 25750995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin C-Terminus Guanidine Modifications and Further Insights into an Added Mechanism of Action Imparted by a Peripheral Structural Modification.
    Wu ZC; Cameron MD; Boger DL
    ACS Infect Dis; 2020 Aug; 6(8):2169-2180. PubMed ID: 32598127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total synthesis of [Ψ[C(═NH)NH]Tpg(4)]vancomycin and its (4-chlorobiphenyl)methyl derivative: impact of peripheral modifications on vancomycin analogues redesigned for dual D-Ala-D-Ala and D-Ala-D-Lac binding.
    Okano A; Nakayama A; Schammel AW; Boger DL
    J Am Chem Soc; 2014 Oct; 136(39):13522-5. PubMed ID: 25211770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A redesigned vancomycin engineered for dual D-Ala-D-ala And D-Ala-D-Lac binding exhibits potent antimicrobial activity against vancomycin-resistant bacteria.
    Xie J; Pierce JG; James RC; Okano A; Boger DL
    J Am Chem Soc; 2011 Sep; 133(35):13946-9. PubMed ID: 21823662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substrate Inhibition of VanA by d-Alanine Reduces Vancomycin Resistance in a VanX-Dependent Manner.
    van der Aart LT; Lemmens N; van Wamel WJ; van Wezel GP
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4930-9. PubMed ID: 27270282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of the d-Ala-d-Lac-Terminated Peptidoglycan Structure in Vancomycin-Resistant Enterococcus faecalis Using a Combined Solid-State Nuclear Magnetic Resonance and Mass Spectrometry Analysis.
    Chang JD; Foster EE; Yang H; Kim SJ
    Biochemistry; 2017 Jan; 56(4):612-622. PubMed ID: 28040891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of the structure of vancomycin binding pocket in designing compounds active against vancomycin-resistant enterococci (VRE).
    Jia Y; Bois-Choussy M; Malabarba A; Brunati C; Zhu J
    J Antibiot (Tokyo); 2006 Sep; 59(9):543-52. PubMed ID: 17136887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide/β-Peptoid Hybrids with Activity against Vancomycin-Resistant Enterococci: Influence of Hydrophobicity and Structural Features on Antibacterial and Hemolytic Properties.
    Vestergaard M; Skive B; Domraceva I; Ingmer H; Franzyk H
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total synthesis of [Ψ[C(═S)NH]Tpg4]vancomycin aglycon, [Ψ[C(═NH)NH]Tpg4]vancomycin aglycon, and related key compounds: reengineering vancomycin for dual D-Ala-D-Ala and D-Ala-D-Lac binding.
    Xie J; Okano A; Pierce JG; James RC; Stamm S; Crane CM; Boger DL
    J Am Chem Soc; 2012 Jan; 134(2):1284-97. PubMed ID: 22188323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin analogs: Seeking improved binding of d-Ala-d-Ala and d-Ala-d-Lac peptides by side-chain and backbone modifications.
    Leung SS; Tirado-Rives J; Jorgensen WL
    Bioorg Med Chem; 2009 Aug; 17(16):5874-86. PubMed ID: 19620008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of a dimeric derivative of vancomycin to L-Lys-D-Ala-D-lactate in solution and at a surface.
    Rao J; Yan L; Lahiri J; Whitesides GM; Weis RM; Warren HS
    Chem Biol; 1999 Jun; 6(6):353-9. PubMed ID: 10375541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D-Ala-D-lac binding is not required for the high activity of vancomycin dimers against vancomycin resistant enterococci.
    Jain RK; Trias J; Ellman JA
    J Am Chem Soc; 2003 Jul; 125(29):8740-1. PubMed ID: 12862465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptidoglycan O-acetylation increases in response to vancomycin treatment in vancomycin-resistant Enterococcus faecalis.
    Chang JD; Foster EE; Wallace AG; Kim SJ
    Sci Rep; 2017 Apr; 7():46500. PubMed ID: 28406232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total synthesis and evaluation of [Psi[CH2NH]Tpg4]vancomycin aglycon: reengineering vancomycin for dual D-Ala-D-Ala and D-Ala-D-Lac binding.
    Crowley BM; Boger DL
    J Am Chem Soc; 2006 Mar; 128(9):2885-92. PubMed ID: 16506767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin-resistant enterococci.
    Gin AS; Zhanel GG
    Ann Pharmacother; 1996 Jun; 30(6):615-24. PubMed ID: 8792949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VanD-type vancomycin-resistant Enterococcus faecium and Enterococcus faecalis.
    Depardieu F; Kolbert M; Pruul H; Bell J; Courvalin P
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3892-904. PubMed ID: 15388450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-kill study and synergistic activity of cell-wall inhibitor antibiotics in combination with gentamicin against Enterococcus faecalis and Enterococcus faecium.
    Aligholi M; Emaneini M; Taherikalani M; Shahsavan S; Jabalameli F; Asadollahi P; Khoramian B; Eslampour MA
    Acta Microbiol Immunol Hung; 2011 Sep; 58(3):219-26. PubMed ID: 21983323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-Terminus Alkylation of Vancomycin: Ligand Binding Affinity, Antimicrobial Activity, and Site-Specific Nature of Quaternary Trimethylammonium Salt Modification.
    Wu ZC; Isley NA; Boger DL
    ACS Infect Dis; 2018 Oct; 4(10):1468-1474. PubMed ID: 30067012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.